FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION BEZAFIBRATE FAST DISSOLVING TABLETSg[p[pv
Fuente:
Zenodo
Guardado en:
| Autor principal: | |
|---|---|
| Formato: | Recurso digital |
| Lenguaje: | inglés |
| Publicado: |
Zenodo
2026
|
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
| _version_ | 1866901351272808448 |
|---|---|
| author | Dr. P. Perumal, S. Selvaraj*, K. Manimekala |
| author_facet | Dr. P. Perumal, S. Selvaraj*, K. Manimekala |
| contents | <p><span>This study aimed to formulate, develop, and evaluate fast-dissolving tablets of bezafibrate using the solid dispersion method. The formulation process focused on enhancing the dissolution rate and bioavailability of bezafibrate, a poorly water-soluble drug. Precompression parameters such as thickness, diameter, hardness, friability, drug content, and weight variation were optimized to ensure the quality and uniformity of the tablets. In vitro evaluation involved assessing dispersion time, wetting time, and dissolution profiles over a three-month period to determine stability under different storage conditions. The findings suggest that the developed bezafibrate fast-dissolving tablets hold promise for improved drug delivery and patient compliance, offering valuable insights into their formulation and performance.</span></p> |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_19627463 |
| institution | Zenodo |
| language | eng |
| publishDate | 2026 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION BEZAFIBRATE FAST DISSOLVING TABLETSg[p[pv Dr. P. Perumal, S. Selvaraj*, K. Manimekala <p><span>This study aimed to formulate, develop, and evaluate fast-dissolving tablets of bezafibrate using the solid dispersion method. The formulation process focused on enhancing the dissolution rate and bioavailability of bezafibrate, a poorly water-soluble drug. Precompression parameters such as thickness, diameter, hardness, friability, drug content, and weight variation were optimized to ensure the quality and uniformity of the tablets. In vitro evaluation involved assessing dispersion time, wetting time, and dissolution profiles over a three-month period to determine stability under different storage conditions. The findings suggest that the developed bezafibrate fast-dissolving tablets hold promise for improved drug delivery and patient compliance, offering valuable insights into their formulation and performance.</span></p> |
| title | FORMULATION, DEVELOPMENT AND IN VITRO EVALUATION BEZAFIBRATE FAST DISSOLVING TABLETSg[p[pv |
| url | https://doi.org/10.5281/zenodo.19627463 |